Home › Myelofibrosis › Colorado
Myelofibrosis clinical trials in Colorado
6 studies for Myelofibrosis are looking for participants at sites in Colorado.
Cities in Colorado
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Blood Cancer Center, Denver
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT04176198A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
- Colorado Blood Cancer Institute, Denver
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07469891Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- University of Colorado Anschutz Medical Campus, Aurora
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT05320198A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- Colorado Blood Cancer Institute, Denver
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07008118SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Aurora
- Massive Bio SYNERGY-AI site, Denver
- Massive Bio SYNERGY-AI site, Littleton
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
- Rocky Mountain Cancer Centers - Aurora, Aurora
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2025 · NCT06479135From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.